Human CD55/DAF quantitates human CD55/DAF in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human CD55/DAF.
Human CD55/DAF quantitates human CD55/DAF in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human CD55/DAF.
CD55 (acceleration factor of decay, DAF) is a membrane glycoprotein anchored by GPI that protects autologous cells from the classical and alternative path of the complement cascade. Two-way interactions between CD55 and CD97 are involved in T cell regulation and CD55 can regulate the complement when it is bound to CD97. In tumours, CD55 promotes neoangiogenesis, tumourigenesis, invasiveness and avoidance of apoptosis. CD55 is a 70 kDa glycoprotein (in erythrocytes) anchored to the membrane by the glycosylphosphatidylinositol tail. In other cells, the apparent molecular weight is slightly greater for CD55s and has a substantial O-glycan content. The CD55 binds to C4b or C3b complement fragments activated on the cell surface, preventing assembly and accelerating the degradation of conventional and alternative pathways. CD55 carries antigens from blood groups associated with Cromer. Two replacement CD55-encoded transcribables were identified and the predominant transcript encodes a membrane-bound protein expressed on cells exposed to plasma components proteins, but a spliced transcription produces a soluble protein at much lower levels. CD55 was studied to play a role in the growth and survival of prostate cancer.
Sensitivity
Sensitivity of dosage: 0.85 ng/ml.
Measurement range
Dose range: 0.85 to 200 ng/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Samples
Type of sample: Plasma, Serum, Surnatant (Serum volume, 50 µl; plasma, 50 µl; supernatant, 50 µl).
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 17145329 |
| Specifications |
| Accession number | CD55; CD55 antigen; CD55 molecule (Crmer blood group); CD55 molecule, degradation acceleration factor for complement; CD55 molecule, degradation acceleration factor for complement (Crmer blood group); Cd55a ; factor of acceleration of the degradation of the compound |
| Dose range | 0.85 to 200 ng/ml |
| Sensitivity of the dosage | 0.85 ng/ml |
| Conjugate | Biotin |
| Product type | ELISA |
| Type of sample | Plasma, Serum, Surnatant |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | P08174 |
| Gene symbol(s) | CD55 |
| Coefficient of inter-dose variation | <12% |
| Coefficient of intra-dose variation | <10% |
| Contents of kits | 96 pre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids |
| Marker or dye | HRP |
| Quantity | 5 x 96 tests |
| Regulatory status | Use exclusively for research |
| Target | CD55 |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Serum, 50 µl; plasma, 50 µl; supernatant, 50 µl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h 45 min |
Origin and customs
| Manufacturer ref. | EH93RBX5 |
|---|
| Country of origin | United States |
|---|
A question or a specific configuration?
Contact us for a quote.